Designed specifically to meet expediting needs in biotechnology and medical research, biochips are touted as revolutionary aids to comprehend biochemical reactions specific to cell development. Growing burden of chronic ailments often resulting in morbidity and fatality are ripe factors prompting thorough advances in biochip market. In contrast to conventionally used bulky lab equipment and isolated laboratory settings, high tech biochips have emerged as the next plausible solutions to farther advances in biotechnology.

Biochips are designed to accurately sense DNA activities, comprising DNA oxidation, binding and reduction, further encoding the data into a computer readable forma

Designed specifically to meet expediting needs in biotechnology and medical research, biochips are touted as revolutionary aids to comprehend biochemical reactions specific to cell development. Growing burden of chronic ailments often resulting in morbidity and fatality are ripe factors prompting thorough advances in biochip market. In contrast to conventionally used bulky lab equipment and isolated laboratory settings, high tech biochips have emerged as the next plausible solutions to farther advances in biotechnology.

Biochips are designed to accurately sense DNA activities, comprising DNA oxidation, binding and reduction, further encoding the data into a computer readable format for further R&D, in a human friendly language. On the back of surged cancer instances, medical practitioners are consistently vouching for advanced preventive diagnosis to gauge likelihood of the disease in an otherwise healthy population. Biochip has been a major breakthrough in pursuing preventive therapeutics even before the onset of tangible symptoms. Biochips are highly efficient solutions to garner insights on multiple disease symptoms. Factors as such are likely to trigger incremental growth opportunity in global biochip market in the forthcoming years.

New Printing Technology to Further Enhance Biochip Functionalities in Genomics

In recent years, technology remains the kingpin in bolstering advances in medical R&D, with biochip development not being an exception. 3D printing has been ushering revolutionary medical devices, also encompassing biochip designing. In a recent development, researchers in Advanced Science Research Center (ASRC) have invented a judicious means to produce biochips. The researchers have successfully employed microfluidic tactics in association with beam pen lithography over photochemical surface to attain improved biochip printing technology.

The technology is revolutionary as it enables nanoscale printing to enable complex imprints onto biochips, thereby improving functionalities. The printing technology also assists in leveraging reliable printing on materials such as lipids, glass and even metals. The development is a significant leap forward in biological research. Milestones as such are poised to coin optimum growth in global biochip market in forthcoming years.

Insufficient Knowledge and Stringent Regulatory Norms to Thwart Growth Scope in Global Biochip Market

Biochips are designed as self-sufficient tiny laboratories to assist in next generation sequencing thereby aid  in treating complex biological shortcomings such as rare-cell, rare molecule analysis. With technology being the propellant, global biochip market is witnessing major disruptions to attain further developments in biochip technology. In a recent development, researchers at Seoul University are enumerating the potential of next generation sequencing mediated by improved biochips.

The global biochip market is slated to remain overtly lucrative with optimistic rise in end-use applications such as drug development, impressive R&D expeditions in bio-array technologies to suit next generation sequencing as well as relentless market extension on the back of new market entrants. However, besides stringent regulatory norms, insufficient knowledge on biochip technology is a crucial growth deterrent in global biochip market.

New Biochip Promises Superlative Diagnosis and Drug Assessment for Glioblastoma

Besides research endeavors, the global biochip market is estimated to remain lucrative with fast track developments in biochip designs. In a recent development, Akay Lab, a biopharm veteran has recently affirmed its breakthrough achievement in developing a microfluidic brain cancer chip that assists simultaneous drug administration as well as facilitates parallel testing of drugs on glioblastoma patients which is one of the most life threatening brain tumors. This newly designed biochip aids in tumor spheroids development and enables accurate analysis on drug combinations. Factors as such are likely to boost robust growth in global biochip market in the coming years.

Lab-on-a-Chip Biochip to Remain a Promising Segment Prompting revenue Maximization

One of the most promising forms of biochips is lab-on-a-chip format that combines diverse laboratory applications on a single dedicated biochip, thereby rendering automation as well as high throughput. Ongoing advances such as integrated microfluidic lab-on-a -chip works on surface acoustic waves and aids in bio-sensing to leverage supersensitive assays within complex media. High end researches affirm the efficacy of SAW based lab-on-a-chip in detecting sub nanometer concentrations in complex media, thus outperforming standard, and commercial gravimetric sensors. It is likely that such developments in lab -on-a-chip biochip could be amply used in detecting biomarkers from biological fluids, thus amplifying growth in global biochip market.

A lab-on-a-chip biochip is a highly compact device that essentially combines microfluids as well as nanotechnology components to facilitate highly complex biochemical analyses across multiple fields such as microarrays and protein analysis and separation. Integrated compact miniature biochip allows DNA amplification as opposed to commonly unemployed thermocyclers catering to miniature single cell. Advances in compact lab-on-a-chip allows high precision and reduces chemical wastes. Further advances such as 3D printing specifically for accommodating high precision miniature stereolithographic needs have emerged in recent years. 3D printing specifically for biochip designing offers tentative solutions for high price cleanroom fabrication as well as support parallel fabrication for multiple devices enabling single print.